InsiderTrades.com logo

TFFP Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 4.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

TFF Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at TFF Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

TFF Pharmaceuticals Share Price & Price History

Current Price: $0.07
Price Change: +0.30 (1.20%)
As of 04/8/2026 01:00 AM ET

This chart shows the closing price history over time for TFFP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

TFF Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/15/2023Carlson Capital L PMajor ShareholderSell8,600$11.00$94,600.00202,600View SEC Filing Icon  
8/15/2023Harlan F WeismanCEOBuy24,000$6.25$150,000.0032,584View SEC Filing Icon  
8/15/2023Stephen RocamboliDirectorBuy800$6.25$5,000.001,440View SEC Filing Icon  
8/15/2023Zamaneh MikhakInsiderBuy4,800$6.25$30,000.005,400View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for TFF Pharmaceuticals (NASDAQ:TFFP)

15.25% of TFF Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TFFP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

TFF Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2024Armistice Capital LLC185,695$0.31M0.0%N/A5.990%Search for SEC Filing on Google Icon
7/17/2024Westside Investment Management Inc.50,491$84K0.0%+28.7%1.629%Search for SEC Filing on Google Icon
4/19/2024Westside Investment Management Inc.39,225$0.24M0.1%+382.1%1.557%Search for SEC Filing on Google Icon
2/12/2024AIGH Capital Management LLC29,482$0.21M0.1%-98.9%1.247%Search for SEC Filing on Google Icon
1/12/2024Westside Investment Management Inc.8,136$57K0.0%-81.3%0.343%Search for SEC Filing on Google Icon
1/1/2024Vanguard Group Inc.846,884$0.30M0.0%-0.8%35.734%Search for SEC Filing on Google Icon
11/15/2023Worth Venture Partners LLC646,832$0.23M0.1%+66.2%1.153%Search for SEC Filing on Google Icon
11/13/2023AIGH Capital Management LLC2,655,235$0.93M0.4%+70.7%4.734%Search for SEC Filing on Google Icon
8/8/2023Gagnon Securities LLC161,074$76K0.0%-27.2%0.463%Search for SEC Filing on Google Icon
5/8/2023Sigma Planning Corp155,191$0.11M0.0%+53.8%0.446%Search for SEC Filing on Google Icon
4/10/2023Gagnon Securities LLC221,207$0.15M0.0%+255.3%0.636%Search for SEC Filing on Google Icon
2/16/2023AIGH Capital Management LLC1,739,130$1.83M0.6%N/A4.998%Search for SEC Filing on Google Icon
2/3/2023Sepio Capital LP330,600$0.35M0.0%+4.9%0.950%Search for SEC Filing on Google Icon
1/31/2023Princeton Capital Management LLC101,449$0.11M0.0%-25.7%0.292%Search for SEC Filing on Google Icon
1/24/2023Sigma Planning Corp100,891$0.11M0.0%+31.2%0.290%Search for SEC Filing on Google Icon
11/15/2022Carlson Capital L P275,000$1.12M0.1%-8.3%1.079%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC20,776$84K0.0%N/A0.082%Search for SEC Filing on Google Icon
10/28/2022Sepio Capital LP315,060$1.28M0.1%+222.5%1.237%Search for SEC Filing on Google Icon
8/17/2022Quantum Private Wealth LLC11,082$62K0.0%N/A0.044%Search for SEC Filing on Google Icon
8/9/2022Fermata Advisors LLC27,599$0.16M0.1%+15.7%0.109%Search for SEC Filing on Google Icon
8/1/2022Gagnon Securities LLC284,361$1.61M0.3%+12.4%1.121%Search for SEC Filing on Google Icon
7/28/2022Selective Wealth Management Inc.5,000$28K0.0%+100.0%0.020%Search for SEC Filing on Google Icon
7/26/2022Sepio Capital LP97,700$0.55M0.1%N/A0.385%Search for SEC Filing on Google Icon
7/15/2022Westside Investment Management Inc.51,650$0.29M0.0%+11.8%0.204%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP105,388$0.67M0.1%-18.5%0.415%Search for SEC Filing on Google Icon
4/25/2022Westside Investment Management Inc.46,200$0.29M0.0%+133.6%0.182%Search for SEC Filing on Google Icon
2/15/2022Westside Investment Management Inc.19,775$0.18M0.0%N/A0.078%Search for SEC Filing on Google Icon
2/14/2022PDT Partners LLC27,083$0.24M0.0%-18.7%0.107%Search for SEC Filing on Google Icon
2/14/2022GSA Capital Partners LLP129,241$1.15M0.1%-11.0%0.509%Search for SEC Filing on Google Icon
2/9/2022Princeton Capital Management LLC125,771$1.12M0.3%-1.8%0.496%Search for SEC Filing on Google Icon
2/8/2022Gagnon Securities LLC252,473$2.24M0.3%-10.5%0.995%Search for SEC Filing on Google Icon
2/4/2022IndexIQ Advisors LLC31,121$0.28M0.0%-6.1%0.123%Search for SEC Filing on Google Icon
2/2/2022Fermata Advisors LLC22,435$0.20M0.1%+9.1%0.088%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
TFF Pharmaceuticals logo
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment and prophylaxis of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It also develops other dry powder products, such as Augmenta human derived monoclonal antibodies for the treatment of COVID-19 disease; and other vaccines. It has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs. TFF Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Fort Worth, Texas.
Read More on TFF Pharmaceuticals

Today's Range

Now: $0.07
Low: $0.07
High: $0.07

50 Day Range

MA: $0.06
Low: $0.07
High: $0.07

52 Week Range

Now: $0.07
Low: $0.06
High: $3.23

Volume

N/A

Average Volume

N/A

Market Capitalization

$288.60 thousand

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of TFF Pharmaceuticals?

TFF Pharmaceuticals' top insider shareholders include:
  1. Carlson Capital L P (Major Shareholder)
  2. Lung Therapeutics, Inc (Major Shareholder)
  3. Harlan F Weisman (CEO)
  4. Aaron GL Fletcher (Director)
  5. Zamaneh Mikhak (Insider)
  6. Glenn R Mattes (CEO)
  7. Robert S Mills (Director)
  8. Randy H Thurman (Director)
  9. Stephen Rocamboli (Director)
  10. James Brian Windsor (Insider)
Learn More about top insider investors at TFF Pharmaceuticals.

TFF Pharmaceuticals Active Insiders

Glenn R Mattes
Glenn R Mattes (Age 69)
CEO
Kirk Allen Coleman
Kirk Allen Coleman (Age 53)
CFO
Malcolm Fairbairn
Director